Dr. Trevor Campbell, MD, CCFP
Dr. Trevor Campbell, MD, CCFP
Episode 3: AJ Joseph, Lupin
Episode 3: AJ Joseph, Lupin
Episode 3: AJ Joseph, Lupin
Tuesday 18th May 2021
AJ Joseph reveals his journey from exercise physiology to healthcare finance and the pivotal role of generics in making medicines affordable.
30 minutes
Informative
Inspiring
Educational
Supportive
Engaging
About this podcast
Author:
Dr. Trevor Campbell, MD, CCFP
Overview:
Categories:
Holistic Health Innovations
Mindfulness & Technology in Health
Mindful Recovery
Healing from Sexual Trauma
Innovative Treatments & Recovery Paths
Links:
Visit site
Episodes:
97 (View all)
Do you want to link to this podcast?
Get the buttons here!Generics Uncovered: AJ Joseph's Journey with Lupin Pharmaceuticals
Episode Overview
- Generics play a critical role in reducing healthcare costs.
- AJ Joseph transitioned from exercise physiology to healthcare finance.
- Lupin Pharmaceuticals is committed to ensuring drug supply during COVID-19.
- Innovations in generics involve technology and business model changes.
- Stringent regulations ensure quality and safety of generic drugs.
Generics today make up 90% of prescriptions in the US but only account for 20% of the total cost.
Ever wondered how the healthcare market ticks behind the scenes? This episode of Healthscape brings you a fascinating conversation with AJ Joseph, Vice President at Lupin Pharmaceuticals, as he shares his unique journey through the world of generics and his career transitions from exercise physiology to healthcare finance. AJ opens up about his family's medical background and the expectations he faced, which led him to carve his own path in the healthcare industry.
You'll hear about his experiences in venture capital and corporate development, where he learned the ropes of transforming life science research into commercial products. AJ also dives into the crucial role of generics in making medicines more affordable and accessible, highlighting how they make up a staggering 90% of prescriptions in the US but only 20% of the total cost.
He candidly discusses the challenges and innovations within the generics market, including business model transformations and the evolving landscape of drug manufacturing. AJ addresses concerns about generic drug quality, providing insights into the stringent regulations that ensure safety and effectiveness. The episode also touches on Lupin's efforts during the COVID-19 pandemic, both in the US and India, showcasing their commitment to ensuring supply chains and supporting communities.
AJ's passion for the generics industry shines through as he discusses the future of healthcare and the potential for innovation. Whether you're curious about healthcare finance or just want to understand how generics impact our daily lives, this episode offers valuable insights. So, are you ready to explore how generics are shaping the future of medicine?